KK
RPRX icon

KLP Kapitalforvaltning’s Royalty Pharma RPRX Stock Holding History

KLP Kapitalforvaltning’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.87M Hold
158,200
– – 0.03% 419
2026
Q1 		$7.59M Buy
158,200
+26,700
+20% +$1.17M 0.03% 410
2025
Q4 		$5.08M Sell
131,500
-100
-0.1% -$3.81K 0.02% 490
2025
Q3 		$4.64M Hold
131,600
– – 0.02% 493
2025
Q2 		$4.74M Buy
131,600
+8,300
+7% +$275K 0.02% 483
2025
Q1 		$3.84M Hold
123,300
– – 0.02% 520
2024
Q4 		$3.15M Buy
+123,300
New +$3.27M 0.01% 560

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KLP Kapitalforvaltning's RPRX Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Royalty Pharma (RPRX) position steady in Q2 2026 at 158,200 shares worth $8.87M. The position accounts for 0.03% of the portfolio, ranked #419.

KLP Kapitalforvaltning first reported a position in RPRX in Q4 2024 and has held it in 7 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • KLP Kapitalforvaltning held 158,200 shares of Royalty Pharma worth $8.87M as of Q2 2026.
  • KLP Kapitalforvaltning left its Royalty Pharma share count unchanged in Q2 2026.
  • Royalty Pharma made up 0.03% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #419 holding.
  • KLP Kapitalforvaltning first reported a position in Royalty Pharma in Q4 2024 and has held it in 7 quarters since.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.